FIELD: biotechnology.
SUBSTANCE: invention is related to a method for producing a target protein using a composition of nutrient media for cultivating CHO cells expressing the monoclonal antibody rituximab, including BalanCD HEK293, CDM4HEK293, water for injection at a certain quantitative ratio of components.
EFFECT: invention can be used to increase production of a protein of interest.
2 cl, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
NUTRIENT MEDIA COMPOSITION FOR CULTURING CHO CELLS EXPRESSING MONOCLONAL ANTIBODY PEMBROLIZUMAB | 2024 |
|
RU2836899C1 |
METHOD FOR PRODUCING MONOCLONAL ANTIBODIES OF THERAPEUTIC PURPOSE BY CONTINUOUS CULTIVATION OF CHO CELLS | 2017 |
|
RU2672318C1 |
OPTIMIZATION OF MANUFACTURE OF GL-2045 MULTIMERIZED STRADOMER | 2017 |
|
RU2790232C2 |
METHODS OF PRODUCING AND USING RECOMBINANT ALPHA-1-ANTITRYPSIN (AAT) AND COMPOSITIONS BASED THEREON | 2020 |
|
RU2817416C2 |
METHOD OF PRODUCING RECOMBINANT HYALURONIDASE | 2021 |
|
RU2822202C1 |
METHOD FOR PRODUCTION OF RECOMBINANT PSEUDOADENOVIRUS PARTICLES CONCENTRATE, EXPRESSING HEMAGGLUTININ GENE OF INFLUENZA A/CALIFORNIA/07/2009(H1N1) | 2015 |
|
RU2614127C2 |
METHOD OF PRODUCING HUMAN RECOMBINANT FOLLICLE-STIMULATING HORMONE, PRODUCING CELL LINE AND PLASMID EXPRESSION VECTORS | 2019 |
|
RU2697273C1 |
RATIONALLY DEVELOPED MEDIA FOR CELL CULTIVATION | 2007 |
|
RU2520810C2 |
PLASMID FOR EXPRESSION OF RECOMBINANT HUMAN CHORIONIC GONADOTROPIN (HCG), PLASMID FOR EXPRESSION OF RECOMBINANT ALPHA- AND BETA-SUBUNITS OF HCG, MONOCLONAL LINE OF MAMMALIAN CELLS - PRODUCER OF HCG, METHOD OF PRODUCING RECOMBINANT HCG | 2024 |
|
RU2834784C1 |
RECOMBINANT VESICULAR STOMATITIS VIRUS EXPRESSING CHIMERIC IL12-GMCSF PROTEIN | 2022 |
|
RU2817896C1 |
Authors
Dates
2023-10-02—Published
2023-02-03—Filed